Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Reference55 articles.
1. Raynard B, Balian A, Fallik D, et al.: Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 2002, 35:635–638. Excess weight was found to be a significant risk factor for alcoholic liver disease, including fibrosis, and therefore its correction should be considered in the treatment of alcoholic liver disease.
2. Anton RF, Lieber CS, Tabakoff B: Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcohol Clin Exp Res 2002, 26:1215–1222. This test combination has been validated for the detection of drinking.
3. Volpicelli JR, Alterman AI, Hayashida M, O’Brien CP: Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992, 49:876–880.
4. Lieber CS: Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J Hepatology 2000, 32:113–128.
5. Duce AM, Ortiz P, Cabrero C, Mato JM: S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology 1988, 8:65–68.
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献